Suchergebnisse - "Nakamura, Atsushi"

PubPharm (520)

1

Clinical outcomes in patients with non-small cell lung cancer harboring EGFR Exon20 in-frame insertions in the near-loop and far-loop : Results from LC-SCRUM-Asia

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2024

von Okahisa, M. | Udagawa, H. | Matsumoto, S. | +24

2

The Tumor Immune Microenvironment Is Associated With Recurrence in Early-Stage Lung Adenocarcinoma

enthalten in: JTO clinical and research reports | 2024

von Kanemura, H. | Yokoyama, T. | Nakajima, R. | +27

3

Association of immune-related adverse events with durvalumab efficacy after chemoradiotherapy in patients with unresectable Stage III non-small cell lung cancer

enthalten in: British journal of cancer | 2024

von Haratani, K. | Nakamura, A. | Mamesaya, N. | +22

4

NOTCH1 and CREBBP co-mutations negatively affect the benefit of adjuvant therapy in completely resected EGFR-mutated NSCLC : translational research of phase III IMPACT study

enthalten in: Molecular oncology | 2024

von Ikeda, S. | Tsuboi, M. | Sakai, K. | +29

5

Prophylactic pegfilgrastim reduces febrile neutropenia in ramucirumab plus docetaxel after chemoimmunotherapy in advanced NSCLC : post hoc analysis from NEJ051

enthalten in: Scientific reports | 2024

von Miura, K. | Yamaguchi, O. | Mori, K. | +13

6

A phase II study of atezolizumab with bevacizumab, carboplatin, and paclitaxel for patients with EGFR-mutated NSCLC after TKI treatment failure (NEJ043 study)

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Watanabe, S. | Furuya, N. | Nakamura, A. | +15

7

NOTCH1 and CREBBP co‐mutations negatively affect the benefit of adjuvant therapy in completely resected EGFR‐mutated NSCLC : translational research of phase III IMPACT study

enthalten in: Molecular Oncology | 2024

von Ikeda, S. | Tsuboi, M. | Sakai, K. | +29

8

Lack of Association of Plasma Levels of Soluble Programmed Cell Death Protein 1, Programmed Death-Ligand 1, and CTLA-4 With Survival for Stage II to IIIA NSCLC After Complete Resection and Adjuvant Chemotherapy

enthalten in: JTO clinical and research reports | 2023

von Tanizaki, J. | Kuroda, H. | Yokoyama, T. | +19

9

Evaluation of the effects of pemafibrate on metabolic dysfunction-associated steatotic liver disease with hypertriglyceridemia using magnetic resonance elastography combined with fibrosis-4 index and the magnetic resonance imaging-aspartate aminotransferase score

enthalten in: JGH open : an open access journal of gastroenterology and hepatology | 2023

von Ichikawa, T. | Oba, H. | Owada, M. | +4

10

Effectiveness of crizotinib in patients with ROS1-positive non-small-cell lung cancer : real-world evidence in Japan

enthalten in: Future oncology (London, England) | 2023

von Nogami, N. | Nakamura, A. | Shiraiwa, N. | +4

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[52]